Open-Label Placebo for the Treatment of Cancer-Related Fatigue in Patients with Advanced Cancer: A Randomized Controlled Trial

BACKGROUND: The purpose of this study was to determine the effects of an open-labeled placebo (OLP) compared to a waitlist control (WL) in reducing cancer-related fatigue (CRF) in patients with advanced cancer using Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F). MATERIALS AND ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Yennurajalingam, Sriram, Azhar, Ahsan, Lu, Zhanni, Rodriguez, Ashley J, Arechiga, Adrienne B, Guerra-Sanchez, Maria, Stanton, Penny, Andersen, Clark R, Urbauer, Diana L, Bruera, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Symptom Management and Supportive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732231/
https://www.ncbi.nlm.nih.gov/pubmed/36106759
http://dx.doi.org/10.1093/oncolo/oyac184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732231/
https://www.ncbi.nlm.nih.gov/pubmed/36106759
http://dx.doi.org/10.1093/oncolo/oyac184

Ejemplares similares